PHARMAGREEN BIOTECH INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
PHARMAGREEN BIOTECH INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$390.29 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$162.93K, a 164.67% decline year-over-year.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$266.73K.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was $39.37K.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$110.42K.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$875.50K.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$4.53M.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$2.48M.
- PHARMAGREEN BIOTECH INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$768.81K.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$162.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$429.66K derived: sum of 2 quarters · filed 2023-08-14 | -$390.29K 10-Q · filed 2023-08-14 | -$500.71K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2023-03-31 | -$266.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | -$227.36K 10-Q · filed 2023-05-19 | -$337.78K derived: sum of 3 quarters · filed 2023-05-19 | -$85.84K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-12-31 | $39.37K 10-Q · filed 2023-02-14 | -$71.05K derived: sum of 2 quarters · filed 2023-02-14 | $180.89K derived: sum of 3 quarters · filed 2023-08-14 | -$817.41K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-09-30 | -$110.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $141.51K derived: sum of 2 quarters · filed 2023-08-14 | -$856.78K derived: sum of 3 quarters · filed 2023-08-14 | -$875.50K 10-K · filed 2023-01-17 | ||
| 2022-06-30 | $251.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$746.36K derived: sum of 2 quarters · filed 2023-08-14 | -$765.08K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$998.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | -$1.02M 10-Q · filed 2023-05-19 | ||||
| 2021-12-31 | -$18.72K 10-Q · filed 2023-02-14 | |||||
| 2021-09-30 | -$4.53M 10-K · filed 2023-01-17 | |||||
| 2021-03-31 | -$3.14M 10-Q · filed 2021-05-24 | -$3.56M 10-Q · filed 2021-05-24 | ||||
| 2020-09-30 | -$912.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-29 | -$2.27M derived: sum of 2 quarters · filed 2021-12-29 | -$2.28M derived: sum of 3 quarters · filed 2021-12-29 | -$2.48M 10-K · filed 2021-12-29 | ||
| 2020-06-30 | -$1.36M 10-Q · filed 2020-08-19 | -$1.36M derived: sum of 2 quarters · filed 2021-05-24 | -$1.57M 10-Q · filed 2020-08-19 | -$1.79M derived: sum of 4 quarters · filed 2021-05-24 | ||
| 2020-03-31 | -$3.51K 10-Q · filed 2021-05-24 | -$3.63K 10-Q · filed 2020-05-19 | -$209.53K 10-Q · filed 2021-05-24 | -$209.68K 10-Q · filed 2020-05-19 | -$433.82K derived: sum of 3 quarters · filed 2021-05-24 | -$491.57K derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | -$206.06K 10-Q · filed 2020-08-19 | -$430.31K derived: sum of 2 quarters · filed 2021-01-08 | -$488.06K derived: sum of 3 quarters · filed 2021-01-08 | -$581.92K derived: sum of 4 quarters · filed 2021-01-08 | ||
| 2019-09-30 | -$224.25K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | -$282.00K derived: sum of 2 quarters · filed 2021-01-08 | -$375.87K derived: sum of 3 quarters · filed 2021-01-08 | -$768.81K 10-K · filed 2021-01-08 | ||
| 2019-06-30 | -$57.75K 10-Q · filed 2020-08-19 | -$151.62K derived: sum of 2 quarters · filed 2020-08-19 | -$544.56K 10-Q · filed 2020-08-19 | -$745.75K derived: sum of 4 quarters · filed 2020-08-19 | ||
| 2019-03-31 | -$93.86K 10-Q · filed 2020-08-19 | -$486.81K 10-Q · filed 2020-05-19 | -$688.00K derived: sum of 3 quarters · filed 2020-08-19 | -$1.02M derived: sum of 4 quarters · filed 2020-08-19 | ||
| 2018-12-31 | -$392.94K 10-Q · filed 2020-08-19 | -$594.14K derived: sum of 2 quarters · filed 2020-08-19 | -$923.20K derived: sum of 3 quarters · filed 2020-08-19 | |||
| 2018-09-30 | -$201.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-30 | -$530.25K derived: sum of 2 quarters · filed 2019-12-30 | -$1.07M 10-K · filed 2019-12-30 | |||
| 2018-06-30 | -$329.06K 10-Q · filed 2019-08-19 | -$872.39K 10-Q · filed 2019-08-19 |